{"id":"https://openalex.org/W4286295708","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.4546","title":"LITESPARK-004 (MK-6482-004) phase 2 study of belzutifan, an oral hypoxia-inducible factor 2\u03b1 inhibitor (HIF-2\u03b1), for von Hippel-Lindau (VHL) disease: Update with more than two years of follow-up data.","display_name":"LITESPARK-004 (MK-6482-004) phase 2 study of belzutifan, an oral hypoxia-inducible factor 2\u03b1 inhibitor (HIF-2\u03b1), for von Hippel-Lindau (VHL) disease: Update with more than two years of follow-up data.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286295708","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.4546"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.4546","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.4546","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.4546","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007689146","display_name":"Eric W. Jonasch","orcid":"https://orcid.org/0000-0003-0943-2806","observed_orcids":["https://orcid.org/0000-0003-0943-2806"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Jonasch","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038992904","display_name":"Othon Iliopoulos","orcid":"https://orcid.org/0000-0002-4444-6157","observed_orcids":["https://orcid.org/0000-0002-4444-6157"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Othon Iliopoulos","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082240684","display_name":"W. Kimryn Rathmell","orcid":"https://orcid.org/0000-0002-4984-0225","observed_orcids":["https://orcid.org/0000-0002-4984-0225"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Kimryn Rathmell","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066635849","display_name":"Vivek Narayan","orcid":"https://orcid.org/0000-0002-8205-738X","observed_orcids":["https://orcid.org/0000-0002-8205-738X"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivek Narayan","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022744341","display_name":"Benjamin Louis Maughan","orcid":"https://orcid.org/0000-0002-0010-8551","observed_orcids":["https://orcid.org/0000-0002-0010-8551"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin L. Maughan","raw_affiliation_strings":["University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059690857","display_name":"St\u00e9phane Marie. Oudard","orcid":"https://orcid.org/0000-0003-0893-285X","observed_orcids":["https://orcid.org/0000-0003-0893-285X"]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephane Oudard","raw_affiliation_strings":["Georges Pompidou Hospital, University of Paris, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georges Pompidou Hospital, University of Paris, Paris, France;","institution_ids":["https://openalex.org/I204730241"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004009107","display_name":"Tobias Else","orcid":"https://orcid.org/0000-0002-2262-0011","observed_orcids":["https://orcid.org/0000-0002-2262-0011"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tobias Else","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037818785","display_name":"Jodi Kathleen Maranchie","orcid":"https://orcid.org/0000-0002-8534-9468","observed_orcids":["https://orcid.org/0000-0002-8534-9468"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jodi K. Maranchie","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA;","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029527227","display_name":"Sarah Joanne Welsh","orcid":"https://orcid.org/0000-0001-5690-2677","observed_orcids":["https://orcid.org/0000-0001-5690-2677"]},"institutions":[{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Joanne Welsh","raw_affiliation_strings":["Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I2802466933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009516011","display_name":"Ane Bundsb\u00e6k B\u00f8ndergaard Iversen","orcid":"https://orcid.org/0009-0000-9529-4870","observed_orcids":["https://orcid.org/0009-0000-9529-4870"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Ane Bundsb\u00e6k B\u00f8ndergaard Iversen","raw_affiliation_strings":["Aarhus University Hospital, Aarhus, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aarhus University Hospital, Aarhus, Denmark;","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034406137","display_name":"Ananya Roy","orcid":"https://orcid.org/0000-0002-0706-3237","observed_orcids":["https://orcid.org/0000-0002-0706-3237"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ananya Roy","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100678573","display_name":"Yanfang Liu","orcid":"https://orcid.org/0000-0002-4091-7679","observed_orcids":["https://orcid.org/0000-0002-4091-7679","https://orcid.org/0000-0002-6614-7449"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanfang Liu","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068785092","display_name":"Rodolfo F. Perini","orcid":"https://orcid.org/0009-0002-4400-5260","observed_orcids":["https://orcid.org/0009-0002-4400-5260"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rodolfo F. Perini","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107963543","display_name":"William Marston Linehan","orcid":"https://orcid.org/0000-0001-7983-3109","observed_orcids":["https://orcid.org/0000-0001-7983-3109"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Marston Linehan","raw_affiliation_strings":["Center for Cancer Research, National Cancer Institute, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Research, National Cancer Institute, Bethesda, MD;","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031748968","display_name":"Ramaprasad Srinivasan","orcid":"https://orcid.org/0000-0001-6392-3169","observed_orcids":["https://orcid.org/0000-0001-6392-3169"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramaprasad Srinivasan","raw_affiliation_strings":["Center for Cancer Research, National Cancer Institute, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Research, National Cancer Institute, Bethesda, MD;","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"4546","last_page":"4546"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.03750000149011612,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14326","display_name":"Ear and Head Tumors","score":0.01489999983459711,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/belzutifan","display_name":"belzutifan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hif-2alpha-inhibitor","display_name":"HIF-2\u03b1 inhibitor","score":0.843999981880188},{"id":"https://openalex.org/keywords/von-hippel-lindau-disease","display_name":"von Hippel-Lindau disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.953000009059906},{"id":"https://openalex.org/keywords/pancreatic-neuroendocrine-tumors","display_name":"pancreatic neuroendocrine tumors","score":0.921999990940094},{"id":"https://openalex.org/keywords/oral-targeted-therapy","display_name":"oral targeted therapy","score":0.5270000100135803},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7419999837875366},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.8539999723434448},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.597000002861023},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9070972204208374},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6076549887657166},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5768739581108093},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5679588317871094},{"id":"https://openalex.org/C2778460572","wikidata":"https://www.wikidata.org/wiki/Q460937","display_name":"Hemangioblastoma","level":2,"score":0.5611885190010071},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5283485054969788},{"id":"https://openalex.org/C2778886567","wikidata":"https://www.wikidata.org/wiki/Q741315","display_name":"Von Hippel\u2013Lindau disease","level":3,"score":0.5232906937599182},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5033928751945496},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.4918935298919678},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42622482776641846},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3274005055427551},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.27997732162475586},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.16194024682044983}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.4546","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.4546","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.4546","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410822732","https://openalex.org/W7162578240","https://openalex.org/W4393988560","https://openalex.org/W4407701555","https://openalex.org/W3166814466","https://openalex.org/W4295837534","https://openalex.org/W7133211193","https://openalex.org/W4409392915","https://openalex.org/W4409805981","https://openalex.org/W7148876285"],"abstract_inverted_index":{"4546":[0],"Background:":[1],"VHL":[2,25,68,100,156,423,455],"disease":[3,69,139,210],"is":[4],"associated":[5,39,74],"with":[6,40,67,98,290,438],"malignant":[7],"or":[8,78,129,143,389],"benign":[9],"tumors,":[10],"including":[11,426],"renal":[12,182],"cell":[13],"carcinoma":[14],"(RCC),":[15],"pancreatic":[16],"neuroendocrine":[17],"tumors":[18],"(pNETs),":[19],"and":[20,30,122,176,183,218,232,294,403,429],"hemangioblastomas.":[21],"Alterations":[22],"in":[23,46,155,173,181,212,283,309,332,370,422],"the":[24,47,57,62,204,374,433,446],"gene":[26],"cause":[27],"aberrant":[28],"stabilization":[29],"accumulation":[31],"of":[32,37,59,64,92,109,127,178,200,247,398,413,440,448],"HIF-2\u03b1,":[33],"leading":[34],"to":[35,56,221,273,305,328,350,418],"activation":[36],"genes":[38],"tumor":[41,108],"growth.":[42],"Antitumor":[43],"activity":[44,421],"observed":[45],"ongoing":[48],"open-label":[49],"phase":[50],"2":[51,90,291,405],"study,":[52],"LITESPARK-004":[53],"(NCT03401788),":[54],"led":[55],"approval":[58],"belzutifan":[60,133,416,449],"for":[61,73,207,454],"treatment":[63,198,396,453],"patients":[65],"(pts)":[66],"who":[70],"require":[71],"therapy":[72],"RCC,":[75,427],"CNS":[76,237,310,430],"hemangioblastomas,":[77,431],"pNETs":[79],"not":[80,301,324,346],"requiring":[81],"immediate":[82,115],"surgery.":[83],"Updated":[84],"results":[85,444],"are":[86],"presented":[87],"after":[88,359],">":[89,110],"years":[91,264],"follow-up.":[93],"Methods:":[94],"Pts":[95],"(\u226518":[96],"years)":[97],"germline":[99],"alterations,":[101],"\u22651":[102,230,236,259],"measurable":[103],"nonmetastatic":[104],"RCC":[105,158,213,284],"tumor,":[106],"no":[107,117],"3":[111,263,317,339,363],"cm":[112],"that":[113,439],"necessitated":[114],"surgery,":[116],"prior":[118,253],"anticancer":[119],"systemic":[120,452],"treatment,":[121],"an":[123],"ECOG":[124],"PS":[125],"score":[126],"0":[128],"1":[130,401],"received":[131],"oral":[132],"120":[134],"mg":[135],"once":[136],"daily":[137],"until":[138],"progression,":[140],"unacceptable":[141],"toxicity,":[142],"pt":[144,219,384],"withdrawal.":[145],"The":[146],"primary":[147,205],"end":[148,168],"point":[149],"was":[150,277,285,300,312,323,334,345,377],"objective":[151],"response":[152,179],"rate":[153],"(ORR)":[154],"disease\u2013associated":[157],"per":[159,186],"RECIST":[160,187],"v1.1":[161,188],"by":[162,189,240],"independent":[163],"central":[164],"review":[165],"(ICR).":[166],"Secondary":[167],"points":[169],"were":[170,196,209,368],"safety,":[171],"ORR":[172,282,308,331],"non-RCC":[174],"neoplasms,":[175,185,425],"duration":[177],"(DOR)":[180],"nonrenal":[184],"ICR.":[190],"Results:":[191],"Of":[192],"61":[193],"pts,":[194],"50":[195,233],"on":[197],"as":[199,450],"July":[201],"15,":[202],"2021;":[203],"reasons":[206],"discontinuation":[208],"progression":[211],"neoplasms":[214],"(n":[215,223,249,287,314,336,379],"=":[216,224,250,288,315,337,380],"4)":[217],"decision":[220],"withdraw":[222],"4).":[225],"Twenty":[226],"pts":[227,248,257,354,372,393],"(33%)":[228],"had":[229,235,252,258,385],"pNET":[231],"(82%)":[234],"hemangioblastoma":[238],"evaluable":[239],"ICR":[241],"at":[242],"baseline.":[243],"At":[244],"baseline,":[245],"97%":[246],"59)":[251],"VHL-related":[254,260,357],"surgery;":[255],"38":[256],"surgery":[261],"within":[262],"before":[265],"starting":[266,360],"belzutifan.":[267,361],"Median":[268,298],"time":[269],"from":[270],"first":[271],"dose":[272],"database":[274],"cutoff":[275],"date":[276],"29.3":[278,414],"mo":[279],"(range,":[280,303,326,348],"27.6-37.5).":[281],"59%":[286],"36),":[289],"CRs":[292],"(3%)":[293,394],"34":[295],"PRs":[296],"(56%).":[297],"DOR":[299,322,344],"reached":[302,325,347],"8.3+":[304],"27.6+":[306],"mo).":[307,330,352],"hemangioblastomas":[311],"38%":[313],"19;":[316],"CRs;":[318,340],"16":[319],"PRs);":[320,342],"median":[321,343,411],"3.7+":[327],"28.0+":[329],"pNETS":[333],"90%":[335],"18;":[338],"15":[341],"11.0+":[349],"31.0+":[351],"Three":[353],"(5%)":[355],"underwent":[356],"surgeries":[358],"Grade":[362],"treatment-related":[364],"adverse":[365],"events":[366],"(TRAEs)":[367],"reported":[369],"10":[371],"(16%);":[373],"most":[375],"common":[376],"anemia":[378],"6":[381],"[10%]).":[382],"No":[383],"a":[386,410,451],"grade":[387,404],"4":[388],"5":[390],"TRAE.":[391],"Two":[392],"stopped":[395],"because":[397],"TRAEs":[399],"(grade":[400],"dizziness":[402],"intracranial":[406],"hemorrhage).":[407],"Conclusions:":[408],"After":[409],"follow-up":[412],"mo,":[415],"continued":[417],"show":[419],"antitumor":[420],"disease\u2013related":[424],"pNETs,":[428],"whereas":[432],"safety":[434],"profile":[435],"remained":[436],"consistent":[437],"previous":[441],"reports.":[442],"These":[443],"support":[445],"use":[447],"disease.":[456],"Clinical":[457],"trial":[458],"information:":[459],"NCT03401788.":[460]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-07-21T00:00:00"}